Akzo Nobel N V S/Adr
(AKZOY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,277,550 | 2,412,860 | 2,149,860 | 2,213,000 | 3,786,120 |
| Receivables | 4,063,380 | 4,396,680 | 4,613,430 | 3,106,000 | 3,702,460 |
| Inventories | 2,680,130 | 2,674,820 | 2,705,320 | 1,781,000 | 2,228,380 |
| Other current assets | 136,520 | 121,780 | 145,340 | 104,000 | 143,440 |
| TOTAL | $9,157,580 | $9,606,140 | $9,613,950 | $7,204,000 | $9,860,400 |
| Non-Current Assets | |||||
| Investments And Advances | 275,810 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 13,083,040 | 13,051,260 | 13,090,580 | 9,206,000 | 12,330,470 |
| TOTAL | $13,358,850 | $13,051,260 | $13,090,580 | $9,206,000 | $12,330,470 |
| Total Assets | $27,677,510 | $27,514,290 | $27,528,070 | $19,707,000 | $26,684,830 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,837,540 | 4,732,270 | 4,812,010 | 3,283,000 | 4,389,040 |
| Accrued Expenses | 891,520 | 0 | 0 | 0 | 0 |
| Other current liabilities | 2,278,940 | 1,288,560 | 1,328,190 | 951,000 | 1,393,070 |
| TOTAL | $6,696,150 | $6,768,480 | $6,828,050 | $5,182,000 | $6,986,600 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,227,750 | 3,923,730 | 4,063,730 | 2,843,000 | 3,824,640 |
| Other Non-Current Liabilities | 2,391,780 | 3,244,050 | 3,233,430 | 2,324,000 | 3,245,630 |
| TOTAL | $7,409,360 | $7,167,780 | $7,297,160 | $5,167,000 | $7,070,270 |
| Total Liabilities | $14,105,510 | $13,936,270 | $14,125,220 | $10,349,000 | $14,056,880 |
| Shareholders' Equity | |||||
| Common Shares | 653,310 | 662,680 | 673,450 | 467,000 | 620,170 |
| Retained earnings | 12,120,490 | 12,507,520 | 12,481,880 | 8,651,000 | 11,298,620 |
| Other shareholders' equity | 732,720 | 375,260 | 214,420 | 226,000 | 697,210 |
| TOTAL | $13,571,990 | $13,578,020 | $13,402,840 | $9,358,000 | $12,627,950 |
| Total Liabilities And Equity | $27,677,500 | $27,514,290 | $27,528,060 | $19,707,000 | $26,684,830 |